Skip to content 
CJC-1295
⭐⭐⭐⭐⭐ 4.98
1,496+ reviews
- Manufactured in US
- Tracked shipping
- Independently Tested
CJC-1295 (No DAC) is a synthetic 29-amino acid peptide analog of Growth Hormone Releasing Hormone (GHRH) used to study pulsatile growth hormone secretion. It serves as a selective tool for investigating the stimulation of the pituitary gland without the extended half-life associated with Drug Affinity Complex (DAC) modifications.
BUNDLE & SAVE
Select Dose:
We Accept:
- 60 Day Guarantee
- Fast Shipping
- Secured Checkout
- Customer Protection & Verified Quality Standards
All international orders are backed by full reship or refund protection for complete peace of mind. Every product at Quantiv Lab is manufactured under strict documented lab standards and comes with batch-verified COAs to ensure purity, consistency, and transparency. No underdosing, no hidden modifications.
Lab Report Available for This Batch (COA)
99% purity verified Click to view
99% purity verified Click to view
GHRH Receptor Binding & GH Secretion
CJC-1295 (No DAC) is a primary focus for researchers studying the signaling pathways of the anterior pituitary gland. Research suggests it acts as a potent GHRH mimetic, binding to specialized receptors to trigger the synthesis and release of growth hormone. Unlike DAC-modified analogs, “No DAC” variants are studied for their ability to maintain the body’s natural pulsatile rhythm, allowing scientists to monitor how exogenous stimulants interact with endogenous somatostatin levels to regulate the somatotropic axis.
Metabolic Homeostasis & Adipose Tissue
In metabolic research, CJC-1295 (No DAC) is used to evaluate the secondary effects of elevated GH levels on lipid metabolism and protein synthesis. Studies in animal models examine how periodic increases in growth hormone influence the mobilization of fatty acids and the preservation of lean tissue mass. Researchers monitor these fluctuations to understand the peptide’s role in substrate oxidation and energy expenditure within diet-induced obesity models.
Cellular Repair & Protein Synthesis
Recent studies have utilized CJC-1295 (No DAC) to investigate its impact on systemic cellular repair mechanisms. By stimulating the release of GH, which in turn triggers the hepatic production of IGF-1, this peptide provides a framework for studying the rate of collagen synthesis and muscle fiber remodeling. Researchers use these models to determine if pulsatile GH release can accelerate the structural restoration of damaged tissues without the risks associated with constant hormone elevation.
Documented Research Protocols (For Scientific Inquiry Only)
- Animal Secretagogue Models
Daily protocols in rodent studies typically utilize doses of 10–30 µg/kg to monitor acute GH spikes and metabolic changes.
- Bibliographic Safety Data
Peer-reviewed pilot research has documented the stability and lack of systemic toxicity in animal models, establishing a high safety ceiling for pulsatile GHRH analogs.
Scientific Citations & Key Authors
- Teichman, S. L., et al. (2006). “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting GH-releasing hormone analog.” Journal of Clinical Endocrinology & Metabolism.
- Ionescu, M., et al. (2006). “Pulsatile secretion of growth hormone and insulin-like growth factor-I in response to CJC-1295.” Endocrinology.
- Batch Documentation
- Same-Day Shipping
- Discreet Packaging
Customer Notice & Product Verification Standards
The research peptide industry often includes temporary suppliers, unverified resellers, and sellers relying on inconsistent or recycled documentation without clear quality control standards. Quantiv Lab was created to provide a more reliable and transparent alternative for researchers and laboratories that value consistency, verified quality, and long-term trust. Every product follows a strict verification process that includes independent batch testing, lot-specific Certificates of Analysis (COAs), and clearly defined quality release standards. Any batch that does not meet internal verification requirements is rejected and never released for distribution — ensuring researchers receive consistent, accurately documented products with every order.
All orders are securely and discreetly packaged using neutral labeling and professional documentation procedures to support safe, smooth, and reliable delivery worldwide.
Trusted by 10K+ Researchers Worldwide
Real labs. Real protocols. Trusted for consistency.
Purity and documentation matched perfectly
Batch number, vial presentation, and stated specifications were all consistent. This level of QC is what keeps my research on track.
K.S. — Sydney · Verified order
Complete Transparency From Packaging to Documentation
Material arrived well-documented with clear batch identifiers and intact packaging. Everything matched the specification sheet precisely, which gave me full confidence in proceeding with my protocol.
A.S. — Chicago, IL · Verified order
Consistency and COA Alignment Were Flawless
Consistency across every vial was exactly as expected. Labeling, batch traceability, and purity data aligned with the COA without any discrepancies. That reliability is essential for reproducible results.
J.R. — San Diego, CA · Verified order
Accurate Labeling and Reliable Sample Integrity
The documentation clarity and sample integrity were excellent. Every detail from concentration to labeling was consistent with what was promised, making the entire process seamless.
L.M. — Miami, FL · Verified order
Strict Quality Control Reflected in Every Detail
What stood out most was the traceability and clean presentation of each batch. COA alignment was exact, and the overall quality control standards are clearly very strict.
N.K. — New York, NY · Verified order
Consistently Tested & COA Verified:
At every stage of production, Quantiv Lab batches undergo independent third-party testing for identity, purity, sterility, and quality verification. Each lot is released only after meeting strict research-grade standards and is supported by a batch-specific Certificate of Analysis (COA) for complete transparency and traceability.
This multi-step verification process helps ensure that every vial accurately matches its documented specifications — giving researchers confidence in the consistency, integrity, and reliability of every batch.
Identity Test
Verified
Verifies the peptide sequence and molecular structure to ensure the correct compound is present in every vial released by Quantiv Lab.
Purity Test
Verified
Measures overall purity and concentration, confirming ≥99% purity on all qualifying batches to maintain research-grade consistency.
Sterility Screening
Verified
Screens for bacteria, fungi, and other microorganisms to ensure all products are handled and processed under sterile conditions.
Endotoxin Testing
Verified
Tests for lipopolysaccharides (LPS) to ensure endotoxin levels remain within strict research safety limits for compliant use.
Why Choose Quantiv Lab?
At Quantiv Lab, every batch is developed with one priority: complete transparency in quality and consistency. Researchers should always know exactly what they are receiving — with no uncertainty, no misleading specifications, and no compromised standards.
All products undergo independent batch verification and are supported by lot-specific Certificates of Analysis (COAs) for full traceability and confidence in every order.
From carefully selected manufacturing partners to strict internal quality control procedures, Quantiv Lab is built for laboratories and researchers seeking clean, reliable compounds and dependable results — not inconsistency or guesswork.
Verified Batch Testing Standards
Every batch is manufactured through carefully vetted production partners and released only after passing independent third-party verification for identity and purity using HPLC, MS, or equivalent analytical testing methods where applicable. Any batch that fails to meet established quality standards is rejected and never released for distribution.
Formula Transparency
Every batch is sourced through carefully selected synthesis partners and undergoes independent third-party testing for identity and purity using HPLC, MS, or equivalent analytical methods where applicable. Products that do not meet established quality specifications are rejected and never released for distribution.
Safety & Compliance Standards
Every batch is manufactured through trusted synthesis partners and undergoes independent third-party testing for identity, purity, and quality verification using HPLC, MS, or equivalent analytical methods where appropriate. Any product that does not meet strict compliance and quality standards is rejected and never released for distribution.
Lab Report Available for This Batch
99% purity verified Click to view
99% purity verified Click to view
GHRH Receptor Binding & GH Secretion
CJC-1295 (No DAC) is a primary focus for researchers studying the signaling pathways of the anterior pituitary gland. Research suggests it acts as a potent GHRH mimetic, binding to specialized receptors to trigger the synthesis and release of growth hormone. Unlike DAC-modified analogs, “No DAC” variants are studied for their ability to maintain the body’s natural pulsatile rhythm, allowing scientists to monitor how exogenous stimulants interact with endogenous somatostatin levels to regulate the somatotropic axis.
Metabolic Homeostasis & Adipose Tissue
In metabolic research, CJC-1295 (No DAC) is used to evaluate the secondary effects of elevated GH levels on lipid metabolism and protein synthesis. Studies in animal models examine how periodic increases in growth hormone influence the mobilization of fatty acids and the preservation of lean tissue mass. Researchers monitor these fluctuations to understand the peptide’s role in substrate oxidation and energy expenditure within diet-induced obesity models.
Cellular Repair & Protein Synthesis
Recent studies have utilized CJC-1295 (No DAC) to investigate its impact on systemic cellular repair mechanisms. By stimulating the release of GH, which in turn triggers the hepatic production of IGF-1, this peptide provides a framework for studying the rate of collagen synthesis and muscle fiber remodeling. Researchers use these models to determine if pulsatile GH release can accelerate the structural restoration of damaged tissues without the risks associated with constant hormone elevation.
Documented Research Protocols (For Scientific Inquiry Only)
- Animal Secretagogue Models
Daily protocols in rodent studies typically utilize doses of 10–30 µg/kg to monitor acute GH spikes and metabolic changes.
- Bibliographic Safety Data
Peer-reviewed pilot research has documented the stability and lack of systemic toxicity in animal models, establishing a high safety ceiling for pulsatile GHRH analogs.
Scientific Citations & Key Authors
- Teichman, S. L., et al. (2006). “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting GH-releasing hormone analog.” Journal of Clinical Endocrinology & Metabolism.
- Ionescu, M., et al. (2006). “Pulsatile secretion of growth hormone and insulin-like growth factor-I in response to CJC-1295.” Endocrinology.
Dual GIP/GLP-1 Receptor Agonist
Two metabolic pathways in one compound — the step up from semaglutide that changed the incretin landscape.
Tirzepatide activates both GIP and GLP-1 receptors at the same time. Semaglutide only hits one of those (GLP-1). That second pathway — GIP — adds a separate layer of metabolic signaling that affects how the body handles insulin sensitivity, nutrient processing, and energy balance. Published clinical trials showed this dual approach outperformed single-pathway compounds at comparable timepoints.
It sits right in the middle of the incretin hierarchy: semaglutide covers one pathway, tirzepatide covers two, and retatrutide covers three. That makes tirzepatide the key middle piece for understanding what GIP receptor engagement actually adds to the equation — without the added complexity of a third receptor.
- Buyer Protection & Quality Assurance
International orders are fully protected with reship or refund coverage. All products follow documented lab procedures and include batch-verified COAs — no dilution, no hidden changes.
CAS Number
2381089-83-2
Molecular Weight
4,813.45 g/mol
Molecular Formula
C₂₂₅H₃₄₈N₄₈O₆₈
Appearance
White Lyophilized Powder
What Sets Tirzepatide Apart
- Only available dual agonist — hits both GIP and GLP-1 receptors in a single compound
- Outperformed single-pathway compounds — published Phase 3 data showed stronger outcomes than GLP-1-only approaches
- The middle of the hierarchy — sits between semaglutide (1 pathway) and retatrutide (3 pathways) for direct comparison
- Batch Documentation
- Same-Day Shipping
- Discreet Packaging
